Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification with AI-driven Drug Discovery Platform
Antiverse Ltd, a biotechnology company developing a computational antibody drug discovery platform, has announced the […]
ArisGlobal Signs Agreement to Acquire Amplexor Life Sciences
ArisGlobal, the leading provider of life sciences software designed to automate core drug development functions […]
M8 Pharmaceuticals and Daewoong Pharmaceutical Sign Exclusive Licensing Agreement for Envlo™ for Brazil and Mexico
M8 Pharmaceuticals and Daewoong Pharmaceuticals announced they have signed an exclusive licensing agreement whereby M8 […]
Ellodi Pharmaceuticals Welcomes Debra Silberg MD, PhD, FACG to its Board of Directors
Ellodi Pharmaceuticals, a gastroenterology-focused specialty pharmaceutical company dedicated to the continued development of APT-1011, a […]
Action Plan to Tackle Health Inequalities for People Living with Rare Diseases
A new Rare Diseases Action Plan for England will be published today and will ensure […]
GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology
GC Biopharma, a leading provider of biopharmaceutical products in South Korea, announced that it has […]
Oricell Closes $45M Series B1 Financing to Expand Development of Key Products
Oricell Therapeutics, a China-based innovative pharmaceutical company committed to the development of tumor cellular immunotherapeutics, […]
Eluminex Biosciences Closes $40+ Million Series B Financing
Eluminex Biosciences has officially announced the closing of a Series B financing of over $40 […]
Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform
Porton Advanced Solutions and Yinjia Biosciences announced a strategic partnership in developing core protein raw […]
AlloVir Appoints Derek Adams, Ph.D., to Board of Directors
AlloVir, a late-clinical stage allogeneic T cell immunotherapy company, today announced the appointment of Derek […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more